Editorial Expression of Concern: Therapeutic potential of mesenchymal stem/stromal cells (MSCs)-based cell therapy for inflammatory bowel diseases (IBD) therapy

Affiliations

• ¹ Department of Basic Sciences, Faculty of Pharmacy, Middle East University, Amman, 11831, Jordan.
• ² I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
• ³ Department of Surgery, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
• ⁴ Department of Internal Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
• ⁵ School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
• ⁶ Pontifcia Universidad Católica del Perú, Lima, Peru.
• ⁷ Department of Nursing, Young Researchers and Elite Club, Zahedan Branch, Azad University, Zahedan, Iran. amir.rigi1984@gmail.com.
• ⁸ Virology Department, Faculty of Veterinary Medicine, The University of Tehran, Tehran, Iran. abedikiasari.b@ut.ac.ir.